AU2015203365B2 - Homologous recombination in an algal nuclear genome - Google Patents

Homologous recombination in an algal nuclear genome Download PDF

Info

Publication number
AU2015203365B2
AU2015203365B2 AU2015203365A AU2015203365A AU2015203365B2 AU 2015203365 B2 AU2015203365 B2 AU 2015203365B2 AU 2015203365 A AU2015203365 A AU 2015203365A AU 2015203365 A AU2015203365 A AU 2015203365A AU 2015203365 B2 AU2015203365 B2 AU 2015203365B2
Authority
AU
Australia
Prior art keywords
dna
sequence
interest
nuclear
bps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015203365A
Other versions
AU2015203365A1 (en
Inventor
Oliver Kilian
Bertrand Vick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurora Algae Inc
Original Assignee
Aurora Algae Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/581,812 external-priority patent/US8865468B2/en
Application filed by Aurora Algae Inc filed Critical Aurora Algae Inc
Priority to AU2015203365A priority Critical patent/AU2015203365B2/en
Publication of AU2015203365A1 publication Critical patent/AU2015203365A1/en
Application granted granted Critical
Publication of AU2015203365B2 publication Critical patent/AU2015203365B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Exemplary transformation methods are provided for introducing deoxyribonucleic acid (DNA) into the nucleus of an algal cell. A transformation construct may be prepared, with the transformation construct having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA, a second sequence of DNA similar to a corresponding second sequence of the nuclear DNA, and a sequence of DNA of interest inserted between the first and second sequences of DNA of the transformation construct. A target sequence of DNA inserted between the first and second corresponding sequences of the nuclear DNA may be transformed, resulting in replacement of the target sequence of DNA with the sequence of DNA of interest. Also provided are exemplary transformation constructs, with some transformation constructs having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA of an algal cell, a second sequence of DNA similar to a corresponding second sequence of nuclear DNA of the algal cell, and a sequence of DNA of interest inserted between the first and second sequences of the transformation construct. WO 2011/049995 PCT/US2010/053265 Prepare Transformation Construct 210 Transform Target Sequence of Nuclear DNA 220 Select Transformed Cells 230

Description

HOMOLOGOUS RECOMBINATION IN AN ALGAL NUCLEAR
GENOME
Inventors: Oliver Kilian and Bertrand Vick
CROSS-REFERENCE TO RELATED APPLICATIONS
[001] The present application is related to U.S. Non-Provisional Patent Application Serial No. 12/480,635 filed on June 8,2009, titled "VCP-Based Vectors for Algal Cell Transformation," which is hereby incorporated by reference.
[002] The present application is related to U.S. Non-Provisional Patent Application Serial No. 12/480,611 filed on June 8,2009, titled "Transformation of Algal Cells," which is hereby incorporated by reference.
REFERENCE TO SEQUENCE LISTINGS
[003] The present application is filed with sequence listing(s) attached hereto and incorporated by reference. BACKGROUND OF THE INVENTION Field of the Invention [004] This invention relates to molecular biology, and more specifically, to the expression of exogenous DNA elements in algal cells.
Description of Related Art [005] Manipulating the DNA of a cell may confer upon the cell new abilities. For example, a transformed cell (i.e., a cell that has taken-up exogenous DNA) may be more robust than the wild-type cell. For many so-called model biological systems (i.e., well-studied organisms), the DNA elements for transformation have been developed. For other organisms, of which less is known, transformation is a major milestone that must be achieved to facilitate genetic engineering. Complicating this challenge is the need for efficient, non-random transformation of these organisms. Accordingly, there is a need for homologous recombination in an algal nuclear genome.
SUMMARY OF THE INVENTION
[006] Provided herein are exemplary transformation methods for introducing deoxyribonucleic acid (DNA) into the nucleus of an algal cell. A transformation construct may be prepared, with the transformation construct having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA, a second sequence of DNA similar to a corresponding second sequence of the nuclear DNA, and a sequence of DNA of interest inserted between the first and second sequences of DNA of the transformation construct. A target sequence of DNA inserted between the first and second corresponding sequences of the nuclear DNA may be transformed, resulting in replacement of the target sequence of DNA with the sequence of DNA of interest. In further exemplary embodiments, the sequence of DNA of interest may comprise an antibiotic resistance marker, a promoter sequence and an antibiotic resistance marker, or a gene for nutrient assimilation or biosynthesis of a metabolite. A phenotypic characteristic of the algal cell may be changed or new characteristics may be imparted to the algal cell.
[007] Also provided is an exemplary transformation construct, the transformation construct having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA of an algal cell, a second sequence of DNA similar to a corresponding second sequence of nuclear DNA of the algal cell, and a sequence of DNA of interest inserted between the first and second sequences of the transformation construct. According to a further exemplary embodiment, the sequence of DNA of interest may further comprise DNA to compromise or destroy wild-type functioning of a gene for nutrient assimilation or biosynthesis of a metabolite.
[007A] In one particular embodiment the invention provides a transformation method for introducing deoxyribonucleic acid (DNA) into the nucleus of an algal cell, the method comprising: preparing a transformation construct, the transformation construct having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA, the transformation construct having a second sequence of DNA similar to a corresponding second sequence of the nuclear DNA, the transformation construct having a sequence of DNA of interest inserted between the first and second sequences of DNA of the transformation construct, and transforming a target sequence of DNA inserted between the first and second corresponding sequences of the nuclear DNA, resulting in replacement of the target sequence of DNA with the sequence of DNA of interest, wherein the algal cell is of algal genus Nannochloropsis.
[007B] In another particular embodiment the invention provides a transformation construct comprising: a first sequence of DNA similar to a corresponding first sequence of nuclear DNA of an algal cell; a second sequence of DNA similar to a corresponding second sequence of nuclear DNA of the algal cell; and a sequence of DNA of interest inserted between the first and second sequences of the transformation construct, wherein the sequence of DNA of interest comprises a regulatory or promoter sequence.
BRIEF DESCRIPTION OF THE DRAWINGS
[008] FIG. 1 is a diagram showing how exemplary deoxyribonucleic acid (DNA) sequences may be utilized for introducing DNA into the nucleus of an algal cell, according to one exemplary embodiment.
[009] FIG. 2 is a flow chart showing an exemplary method for homologous recombination in an algal nuclear genome.
[0010] FIG. 3 shows an exemplary DNA sequence (SEQ. ID. NO. 1), which includes at least a portion of a nitrate reductase gene.
[0011] FIG. 4 shows an exemplary transformation construct (SEQ. ID. NO. 2), which incorporates nitrate reductase DNA sequences for the flanks of the transformation construct.
[0012] FIG. 5 is a gel showing the molecular genetic analysis of several transformants.
OBJECT
[0012A] It is an object of the present invention to provide a transformation method for introducing DNA into the nucleus of an algal cell or a transformation construct that overcomes or ameliorates at least one of the disadvantages of the prior art. It is a further alternative object to at least provide the public with a useful choice.
DETAILED DESCRIPTION OF THE INVENTION
[0013] FIG. 1 is a diagram showing how exemplary-deoxyribonucleic acid (DNA) sequences may be utilized for introducing DNA into the nucleus of an algal cell, according to one exemplary embodiment. Shown in FIG. 1 is a transformation construct 110, algal nuclear DNA 120, and transformed algal nuclear DNA 130.
[0014] The transformation construct 110 comprises a first sequence of DNA A' that is similar in length and sequence to a corresponding first sequence of algal nuclear DNA A, as found in the algal nuclear DNA 120. The transformation construct 110 comprises a second sequence of DNA C' that is similar in length and sequence to a corresponding second sequence of the nuclear DNA C as found in the algal nuclear DNA 120. The transformation construct 110 further comprises a sequence of DNA of interest X that is inserted between the first A' and second C' sequences of DNA of the transformation construct 110.
[0015] In one exemplary method for introducing DNA into the nucleus of an algal cell, a transformation construct such as exemplary transformation construct 110 is prepared. The transformation construct 110 may then be used to transform a target sequence of DNA B inserted between the first A and second C sequences of the nuclear DNA 120, resulting in replacement of the target sequence of DNA B with the sequence of DNA of interest X.
[0016] According to various exemplary embodiments, the first A' and/or the second C' sequences of DNA similar to the corresponding respective first A and/or the second C sequences of the nuclear DNA 120 may be of any length in base pairs (bps), ranging from approximately 0 bps to approximately 10,000 (bps), or longer. Additionally, the first sequence of DNA A' may or may not have a length in base pairs equal to a length in base pairs of the second sequence of DNA C'.
[0017] In various exemplary embodiments, the target sequence of DNA B inserted between the first A and second C sequences of the nuclear DNA 120 may be of any length in base pairs, ranging from approximately 0 bps to approximately 10,000 (bps), or longer.
[0018] According to some exemplary embodiments, the sequence of DNA of interest X may separate the first A' and second C sequences of the transformation construct 110 by as few as approximately 0 (bps) to as many as approximately 10,000 (bps). The sequence of DNA of interest X may comprise various sequences, such as a regulatory or promoter sequence (uni-directional or bi-directional), an antibiotic resistance marker, or may comprise a promoter sequence and an antibiotic resistance marker. In other exemplary embodiments, the sequence of DNA of interest X may comprise a gene for nutrient assimilation or biosynthesis of a metabolite. For instance, the sequence of DNA of interest X may comprise a gene coding for nitrate reductase or nitrite reductase.
[0019] In various exemplary embodiments, the sequence of DNA of interest X may or may not encode at least a portion of a polypeptide. In some cases, the sequence of DNA of interest X may only be transcribed, however not translated as a polypeptide. In other embodiments, the sequence of DNA of interest X may encode a peptide that is added to a peptide encoded by either the first A or the second C sequence of the nuclear DNA 120. The sequence of DNA of interest X may also encode a non-coding regulatory DNA sequence. In various exemplar}'· embodiments, the sequence of DNA of interest X may not be similar in length to the target sequence of DNA B on the nuclear DNA 120. For instance, the sequence of DNA of interest X may be approximately 0 (bps) in length, resulting in deletion or near deletion of the target sequence of DNA B, as may be observed in the transformed algal nuclear DNA 130.
[0020] According to some exemplary embodiments, the transformation construct 110 may be used to transform a target sequence of DNA B inserted between the first A and second C sequences of the nuclear DNA 120, resulting in replacement of the target sequence of DNA B with the sequence of DNA of interest X. The nuclear DNA 120 may be at least a portion of a genome from the algal genus Nannochloropsis. Further, the genome of the algal genus Nannochloropsis may be a haploid genome. The transformation methodologies described herein may be used to change a phenotypic characteristic of an algal cell to impart new characteristics to the algal cell. For instance, the replacement of the target sequence of DNA B with the sequence of DNA of interest X may be at least a partial replacement, resulting in a partial decrease in gene function of the target sequence of DNA. In other embodiments, the sequence of DNA of interest X may comprise DNA to compromise or destroy wild-type functioning of the target gene B gene, which is otherwise needed for nutrient assimilation or biosynthesis of a metabolite. Conversely, the sequence of DNA of interest X may be used to transform the compromised or destroyed wild-type functioning of the gene for nutrient assimilation or biosynthesis back to wild-type functioning. For instance, the sequence of DNA of interest X may transform an auxotrophic algal cell, resulting in assimilation or biosynthesis of a metabolite. Such transformants may be selected via cultivation in a liquid or solid media that does not include the metabolite required for growth of the transformed auxotrophic algal cell.
[0021] FIG. 2 is a flow chart showing an exemplary method for homologous recombination in an algal nuclear genome.
[0022] At step 210, a transformation construct is prepared. In one exemplary embodiment, the transformation construct 110 (FIG. 1) comprises a first sequence of DNA A' that is similar to a corresponding first sequence of algal nuclear DNA A as found in the algal nuclear DNA 120 (FIG. 1). The transformation construct 110 may also comprise a second sequence of DNA C' that is similar to a corresponding second sequence of the nuclear DNA C as found in the algal nuclear DNA 120. The transformation construct 110 may have a sequence of DNA of interest X inserted between the first A' and second C' sequences of DNA of the transformation construct 110.
[0023] At step 220, a target sequence of nuclear DNA is transformed. According to various exemplary embodiments, the transformation construct 110 is used to transform a target sequence of DNA B inserted between the first A and second C sequences of the nuclear DNA 120, resulting in replacement of the target sequence of DNA B with the sequence of DNA of interest X.
[0024] At step 230, transformed cells are selected. For instance, the sequence of DNA of interest X may transform an auxotrophic algal cell, resulting in assimilation or biosynthesis of a metabolite. Such transformants may be selected via cultivation in a liquid or solid media that does not include tire metabolite required for growth of the transformed auxotrophic algal cell.
[0025] Example.
[0026] In order to test the possibility of homologous recombination in Nannochloropsis, the inventors created a transformation construct which utilized a selectable marker (a bleomycin gene) flanked by a left and a right nitrate reductase DNA sequence.
[0027] FIG. 3 shows an exemplary DNA sequence (SEQ. ID. NO. 1), which includes at least a portion of a nitrate reductase gene.
[0028] Referring to FIG. 3, a left nitrate reductase DNA sequence is designated 310, and a right nitrate reductase DNA sequence is designated 320. As will be described herein, a DNA sequence 315 between flanks 310 and 320 will be displaced from the endogenous nitrate reductase gene with DNA sequences from the transformation construct.
[0029] FIG. 4 shows an exemplary transformation construct (SEQ. ID. NO. 2), which incorporates the nitrate reductase DNA sequences used to create the flanks of the transformation construct. FIG. 4 shows the left nitrate reductase DNA sequence 310', a selection cassette NT7 410, and the right nitrate reductase DNA sequence 320'. The selection cassette NT7 410 comprises a Violaxanthin-chlorophyll a binding protein ("Vcp") 3' UTR, a bleomycin resistance sequence, and a Vcp promoter sequence. The Vcp promoter and the Vcp 3'UTR DNA sequences were obtained from 2 different Vcp gene clusters, as described in U.S. Non-Provisional Patent Application Serial No. 12/480,635 filed on June 8, 2009, titled "VCP-Based Vectors for Algal Cell Transformation. The NT7-cassete comprising the Vcp promoter, bleomycin resistance sequence, and Vcp 3' UTR were inserted in an antiparallel fashion relative to the left nitrate reductase flank 310' and the right nitrate reductase flank 320'.
[0030] DESIGN.
[0031] Primers used.
[0032] Homologous recombination of Vcp ble UTR into NR, reverse direction and deletion of part of one exon [0033] P311 NR LEFT for AGTCGTAGCAGCAGGAATCGACAA.
[0034] P312 NR LEFT rev GGCACACGAGATGGACAAGATCAG T GG AAT AAT G AGGCGG AC AGGGAA.
[0035] P313 NR RIGHT for GTGCCATCTTGTTCCGTCTTGCTT GCGCAAGCCTGAGTACATCATCAA.
[0036] P314 NR RIGHT rev ATGACGGACAAATCCTTACGCTGC.
[0037] P215 NT7 comp for AAGCA AG ACGG AAC A AG AT GGC AC.
[0038] PI 19 PL38 3UTR BACK CTGATCTTGTCCATCTCGTGTGCC.
[0039] PCRs were performed with Takara Taq to generate NR flanks and insertion cassette: [0040] P31 lxP312 on gDNA for Left flank LF (1 kB).
[0041] P313xP314 on gDNA for Right flank RF (1.04kB).
[0042] (NOTE: both flanks contain fusion areas to NT7 derived from primer 312 and 313).
[0043] P215xP119 on NT7 for Insertion construct IC (1.817kB).
[0044] All PCR products were then gel purified.
[0045] The LF, IC and RF fragments were linked with the following PCRs: [0046] ALL 100μΙ PCR RXNs [0047] 170ng of LF + 170ng IC were used in fusion PCR with P311xP215 (2.817 kB)LF-IC.
[0048] 170ng of RF + 170ng IC were used in fusion PCR with P119xP314 (2.821 kB)RF-IC.
[0049] Fragments were gel purified and used for last PCR.
[0050] 170 ng LF-IC + 170 ng RF-IC with P311xP314.
[0051] 3.8 kB DNA Fragment recovered from gel and directly used for transformation.
[0052] TRANSFORMATION.
[0053] 200ng DNA fragment (see above) were used in the previously described transformation protocol.
[0054] Differences: cells were grown in NH4CL-containing F2 media (2 mM NH4C1 instead of nitrate). Recovery after transformation before plating was also done in 2 mM NH4C1 medium.
[0055] Cells were plated on F2 (zeocine-containing) plates with 2 mM NH4CL (instead of 2 mM N03-). All media in 50% salinity compared to seawater.
[0056] SELECTION.
[0057] 200 colonies were picked, resuspended in 100 μΐ nitrogen- , deficient F2 media and spotted on Square plates (F2 media) with different nitrogen sources: [0058] No Nitrogen [0059] 2 mM No2- [0060] 2 mM N03- [0061] 2 mM NH4C1 [0062] The overwhelming majority of these colonies could not grow on nitrate (turned yellowish indicating nitrogen starvation; nitrate reductase knock-out mutants cannot grow on nitrate as the sole nitrogen source), but all clones grew equally well on nitrite and ammonium-chloride plates. Further, appearance of those clones suppressed in growth on nitrate was indistinguishable from cells (transformed or untransformed) grown on nitrogen-deficient (no nitrogen) plates indicating that the growth retardation of mutants on nitrate is due to an inability to use nitrate as a nitrogen source. Growth retardation on agar plates containing nitrate as the sole nitrogen source was never observed with wild types nor with mutants obtained from nitrate reductase unrelated transformation, indicating that the clones were inactivated within the nitrate reductase gene.
[0063] RESULTS.
[0064] FIG. 5 is a gel showing the molecular genetic analysis of several transformants.
[0065] 192 clones were analyzed. 176 of these were apparently nitrate reductase deficient via visual screening. Colonies were also analyzed via PCR. The gel in FIG. 5 shows the molecular genetic analysis of several transformants (designated 1, 2, 7, 9,11 and 12). Clones 2 and 12 have been identified to grow on nitrate as a sole nitrogen source, while clones 1, 7, 9 and 11 could not, indicating a disruption of the nitrate reductase gene.
[0066] The primer used for genetic analysis via PCR would yield a smaller DNA fragment for the wild-type gene and a larger DNA fragment for a mutant gene which contains the large selection marker insertion.
[00067] The lanes labeled 1, 7, 9 and 11 show only one band that corresponds to the nitrate reductase locus with the expected insert. Lanes labeled 2 and 12 show two bands - the smaller band is the endogenous nitrate reductase gene, and the larger band is the transformation construct fragment, which is inserted somewhere else in the genome but not within the nitrate reductase locus.
[0068] SEQUENCING.
[0069] Sequencing was employed to verify if there were errors introduced after recombination. 6 clones were analyzed via PCR, and the flanking regions including the flank ends (5' end of left flank and 3' end of right flank) were sequenced. No error could be found. The entire locus has also been amplified out of transformants (nitrate reductase interrupted by ble gene cassette) and successfully used for repeated transformations of wild-type.
[0070] The inventors were also successful using a wild-type nitrate reductase fragment as a selection marker to rescue a knock out mutant by homologous recombination: the wild-type fragment patched over the insertion site of the ble gene within the nitrate reductase gene and replaced it.
[0071] Only those clones, in which the nitrate reductase gene was rescued by homologous recombination, could grow on nitrate as the sole nitrogen source.
[0072] While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of a preferred embodiment should not be limited by any of the above-described exemplary embodiments.
[0073] Unless the context clearly requires otherwise, throughout the description and the claims, the words "comprise", "comprising", and the like, are to be construed in an inclusive sense as opposed to an exclusive or exhaustiave sense, that is to say, in the sense of "including, but not limited to".
[0074] The reference to any prior art in the specification is not, and should not be taken as, an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge.

Claims (27)

  1. CLAIMS What is claimed is:
    1. A transformation method for introducing deoxyribonucleic acid (DNA) into the nucleus of an algal cell, the method comprising: preparing a transformation construct, the transformation construct having a first sequence of DNA similar to a corresponding first sequence of nuclear DNA, the transformation construct having a second sequence of DNA similar to a corresponding second sequence of the nuclear DNA, the transformation construct having a sequence of DNA of interest inserted between the first and second sequences of DNA of the transformation construct, and transforming a target sequence of DNA inserted between the first and second corresponding sequences of the nuclear DNA, resulting in replacement of the target sequence of DNA with the sequence of DNA of interest, wherein the algal cell is of algal genus Nannochloropsis.
  2. 2. The method of claim Ϊ, wherein the sequence of DNA of interest separates the first and second sequences of DNA similar to the corresponding respective first and second sequence of the nuclear DNA by approximately: (a) 4.5 kb; (b) 10.0 kb; or (c) 200 bps.
  3. 3. The method of claim 1 or claim 2, wherein either the first or second sequence of DNA similar to the corresponding respective first or second sequence of the nuclear DNA comprises approximately: (a) 1000 base pairs (bps); (b) .less than 1000 bps;(c) greater than 1000 bps; (d) greater than 10,000 bps; or (e) 1 base pair to approximately 10,000 bps.
  4. 4. The method of claim 1 or claim 2, wherein each of the first and second sequences of DNA similar to the corresponding respective first and second sequences of the nuclear DNA comprises approximately: (a) 1000 base pairs (bps); (b) less than 1000 bps; (c) greater than 1000 bps; or (d) greater than 10,000 bps.
  5. 5. The method of any one of claims 1 to 4, wherein the sequence of DNA of interest further comprises a regulatory or promoter sequence.
  6. 6. The method of claim 5, wherein the promoter is uni-directional or bidirectional.
  7. 7. The method of any one of claims 1 to 6, wherein the sequence of DNA of interest further comprises an antibiotic resistance marker.
  8. 8. The method of any one of claims 1 to 7, wherein the sequence of DNA of interest further comprises a gene for nutrient assimilation or biosynthesis of a metabolite.
  9. 9. The method of claim 8, wherein the gene codes for nitrate reductase or nitrite reductase.
  10. 10. The method of any one of claims 1 to 8, wherein the sequence of DNA of interest comprises a length in base pairs ranging from approximately 1 base pair to approximately 10,000 base pairs.
  11. 11. The method of any one of claims 1, 3, or 4, wherein the sequence of DNA of interest is approximately 0 bps, resulting in deletion or near deletion of the target sequence of DNA.
  12. 12. The method of any one of claims 1 to 4, wherein the sequence of DNA of interest is transcribed but does not encode a polypeptide.
  13. 13. The method of any one of claims 1 to 6, wherein the sequence of DNA of interest encodes a peptide that is added to a peptide encoded by either the first or the second sequence of nuclear DNA.
  14. 14. The method of any one of claims 1 to 4, wherein the sequence of DNA of interest encodes a non-coding regulatory DNA sequence.
  15. 15. The method of any one of claims 1 to 14, wherein the algal cell is haploid.
  16. 16. The method of any one of claims 1 to 15, the method further comprising: changing a phenotypic characteristic of the algal cell or imparting new characteristics to the algal cell.
  17. 17. The method of any one of claims 1 to 16, wherein the first sequence of DNA similar to the corresponding first sequence of the nuclear DNA has a first length in base pairs which does not equal a second length in base pairs of the second sequence of DNA similar to the corresponding second sequence of the nuclear DNA.
  18. 18. The method of any one of claims 1 to 17, wherein the target sequence of DNA is less than 1 kb.
  19. 19. The method of claim 1, wherein the replacement of the target sequence of DNA with the sequence of DNA of interest is at least a partial replacement resulting in a partial decrease in gene function of the target sequence of DNA.
  20. 20. The method of claim 1, wherein the sequence of DNA of interest further comprises DNA to compromise or destroy wild-type functioning of a gene for nutrient assimilation or biosynthesis of a metabolite.
  21. 21. The method of claim 20, the method further comprising: transforming the compromised or destroyed wild-type functioning of the gene for nutrient assimilation or biosynthesis back to wild-type functioning
  22. 22. The method of claim 20 or claim 21, wherein the gene codes for nitrate reductase or nitrite reductase.
  23. 23. The method of claim 1, wherein the sequence of DNA of interest transforms an auxotrophic algal cell, resulting in assimilation or biosynthesis of a metabolite.
  24. 24. The method of claim 23, the method further comprising selecting the transformed auxotrophic algal cell via cultivation in media that does not include the metabolite required for growth of the transformed auxotrophic algal cell.
  25. 25. The method of claim 24, wherein the media is either solid or liquid.
  26. 26. The method of any one of claims 1 to 25, wherein the algal cell of the algal genus Nannochloropsis is used for the production of biofuels.
    25. The method of claim 24, wherein the media is either solid or liquid.
    26. The method of any one of claims 1 to 25, wherein the algal cell of the algal genus Nannochloropsis is used for the production of biofuels.
  27. 27. A transformation construct comprising. a first sequence of DNA similar to a corresponding first sequence of nuclear DNA of an algal cell; a second sequence of DNA similar to a corresponding second sequence of nuclear DNA of the algal cell; and a sequence of DNA of interest inserted between the first and second sequences of the transformation construct, wherein the sequence of DNA of interest comprises a regulatory or promoter sequence.
AU2015203365A 2009-10-19 2015-06-18 Homologous recombination in an algal nuclear genome Ceased AU2015203365B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015203365A AU2015203365B2 (en) 2009-10-19 2015-06-18 Homologous recombination in an algal nuclear genome

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/581,812 2009-10-19
US12/581,812 US8865468B2 (en) 2009-10-19 2009-10-19 Homologous recombination in an algal nuclear genome
PCT/US2010/053265 WO2011049995A1 (en) 2009-10-19 2010-10-19 Homologous recombination in an algal nuclear genome
AU2010310765A AU2010310765A1 (en) 2009-10-19 2010-10-19 Homologous recombination in an algal nuclear genome
AU2015203365A AU2015203365B2 (en) 2009-10-19 2015-06-18 Homologous recombination in an algal nuclear genome

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010310765A Division AU2010310765A1 (en) 2009-10-19 2010-10-19 Homologous recombination in an algal nuclear genome

Publications (2)

Publication Number Publication Date
AU2015203365A1 AU2015203365A1 (en) 2015-08-13
AU2015203365B2 true AU2015203365B2 (en) 2017-10-19

Family

ID=53836262

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015203365A Ceased AU2015203365B2 (en) 2009-10-19 2015-06-18 Homologous recombination in an algal nuclear genome

Country Status (1)

Country Link
AU (1) AU2015203365B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194029A1 (en) * 2004-05-07 2008-08-14 Peter Hegemann Method for Increasing the Ratio of Homologous to Non-Homologous Recombination
WO2009124070A1 (en) * 2008-03-31 2009-10-08 Kuehnle Agrosystems, Inc. Nuclear based expression of genes for production of biofuels and process co-products in algae

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194029A1 (en) * 2004-05-07 2008-08-14 Peter Hegemann Method for Increasing the Ratio of Homologous to Non-Homologous Recombination
WO2009124070A1 (en) * 2008-03-31 2009-10-08 Kuehnle Agrosystems, Inc. Nuclear based expression of genes for production of biofuels and process co-products in algae

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HALLMANN, A. et al., Gene replacement by homologous recombination in the multicellular green alga Volvox carteri. Proceedings of the National Academy of Sciences of the United States of America, 1997, Vol. 94, pages 7469-7474 *
MINODA, A. et al., Improvement of Culture Conditions and Evidence for Nuclear Transformation by Homologous Recombination in a Red Alga, Cyanidioschyzon merolae 10D. Plant and Cell Physiology, 2004, Vol. 45, No. 6, pages 667-671 *

Also Published As

Publication number Publication date
AU2015203365A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
US8865468B2 (en) Homologous recombination in an algal nuclear genome
US11345933B2 (en) CRISPR enabled multiplexed genome engineering
KR101906491B1 (en) Composition for Genome Editing comprising Cas9 derived from F. novicida
AU2009255947B2 (en) Vcp-based vectors for algal cell transformation
CN107636155B (en) D-amino acid inducible gene expression system of rhodosporidium and rhodotorula
US11976285B2 (en) Maize gene KRN2 and uses thereof
US20120107801A1 (en) High-efficiency homologous recombination in the oil-producing alga, nannochloropsis
CN112481309B (en) Application of Ago protein, composition and gene editing method
AU2015203365B2 (en) Homologous recombination in an algal nuclear genome
KR20190122595A (en) Gene Construct for Base Editing in Plant, Vector Comprising the Same and Method for Base Editing Using the Same
KR20180128864A (en) Gene editing composition comprising sgRNAs with matched 5' nucleotide and gene editing method using the same
EP1718745B1 (en) Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
KR102035654B1 (en) Novel mutant insect cell line producing antimicrobial peptide or a preparation method thereof
Shochatovitz The Role of a MYB2 Gene in Mimulus Cupreus Petal Lobe Anthocyanin Biosynthesis: Design and Construction of a Polycistronic TRNA-gRNA CRISPR/Cas9 MYB2 Knockout Transgene
WO2023199308A1 (en) Systems and methods for genome-scale targeting of functional redundancy in plants
KR20230142207A (en) Monascus ruber having attenuated or deleted MpigI or MpigI' gene, composition and method for increasing monascus pigment production comprising the same
WO2001032845A2 (en) Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
NZ723531B2 (en) Crispr enabled multiplexed genome engineering

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired